Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of gene modified mesenchymal stem cell derived microvesicles in preparation of drugs for treating renal injury

Pending Publication Date: 2021-08-20
西安市第一医院
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is not yet clear whether the function of microvesicles to transport gene information plays an important role in stem cell remodeling and tissue regeneration, and whether it helps stem cells repair damaged tissues through paracrine action, which is very meaningful and worthy of further study Questions discussed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of gene modified mesenchymal stem cell derived microvesicles in preparation of drugs for treating renal injury
  • Applications of gene modified mesenchymal stem cell derived microvesicles in preparation of drugs for treating renal injury
  • Applications of gene modified mesenchymal stem cell derived microvesicles in preparation of drugs for treating renal injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.

[0031] 1. In vitro experiment:

[0032] 1. Culture of human proximal renal tubular epithelial cells (HK2): HK2 was purchased from ATCC, USA. The M199 culture solution containing 5% newborn fetal bovine serum and penicillin / streptomycin (100 μg / L) was used for cultivation in a 37° C. incubator (5% CO 2 ), and the medium was changed every 2 days. When the cell density reaches 80%-90%, it is digested with 0.25% trypsin (containing 1 mmol / L EDTA) and subcultured ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses applications of gene modified mesenchymal stem cell derived microvesicles in preparation of drugs for treating renal injury. Applications of mesenchymal stem cell derived and gene modified miR-34a-MSC-MV, which are specifically designed microvesicles, in preparation of drugs for treating renal injury are included. The level of miR-34a is detected by inducing the overexpression of the miR-34a in MSCs through lentiviral vectors. Through the discovery from pathological observation, the damage level of renal tissue can be obviously improved, renal interstitial fibrosis, lymphocyte infiltration and swelling and necrosis degrees of renal tubules can be obviously alleviated, and renal histopathological scores can be significantly reduced. Through in vivo and in vitro experiments, repair effects of MV and miR-34a-MV are verified; the effects of gene modified stem cells and paracrine products thereof are cleared; and an action mechanism is preliminarily discussed.

Description

technical field [0001] The invention relates to the technical field of stem cell microvesicles, in particular to the application of gene-modified microvesicles derived from bone marrow mesenchymal stem cells in the preparation of drugs for treating kidney damage. Background technique [0002] The incidence rate of Chronic Kidney Disease (CKD) in my country is as high as 11.8%, and it has become another major cause of threatening human health after cardiovascular and cerebrovascular diseases, tumors and diabetes. Tubulointerstitial inflammation and fibrosis are the main pathological basis leading to the progression of CKD, which is characterized by the progressive loss of normal nephrons and the proliferation of a large number of fibroblasts and excessive secretion of extracellular matrix. This process is similar to that after tissue injury. Scar repair rather than normal tissue repair. The current clinical treatment measures can only delay the speed of this scar repair proc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28C12N5/10C12N15/113A61P13/12
CPCA61K35/28A61P13/12C12N5/0663C12N15/113C12N2310/141
Inventor 何娟王妍东瑞娟王汉民
Owner 西安市第一医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com